Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT03436485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03436485
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2026-10-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.